trending Market Intelligence /marketintelligence/en/news-insights/trending/iNRV5mLUOiNGYCLvqt-2pw2 content esgSubNav
In This List

Flexion Therapeutics CFO retires

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Flexion Therapeutics CFO retires

Frederick Driscoll retired as the CFO of Flexion Therapeutics Inc., effective March 31.

Effective upon Driscoll's retirement, Flexion appointed CEO and President Michael Clayman as principal financial officer and principal accounting officer.

Driscoll is continuing to provide services as a part-time, nonexecutive employee while the company completes its on-going search for a new CFO.